The next pathway, ESR1, which was mutated in breast cancer, received microenvironment factor S100A4 to regulate TF ETS1 and SMAD3 through signaling transduction proteins ZNF516, PIK3R1, IDH1, and AKT1. Here, SMAD3 is linked to breast carcinoma.